PRESS RELEASE published on 06/07/2023 at 14:30, 2 years 11 months ago European Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, PhD Named Commander of the Italian Republic for Special Merits
PRESS RELEASE published on 05/25/2023 at 14:30, 2 years 11 months ago Jaguar Announces Over-Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 05/24/2023 at 14:30, 2 years 11 months ago Board Certified Patient Advocate Stacey Tinianov, MPH, Joins Jaguar Health's Scientific Advisory Board
PRESS RELEASE published on 05/23/2023 at 14:30, 2 years 11 months ago Take C.H.A.R.G.E. Registry Marks One-Year Anniversary on National Canine Cancer Awareness Day, With Database Grown 40%
PRESS RELEASE published on 05/19/2023 at 22:15, 3 years ago Jaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 05/16/2023 at 14:30, 3 years ago Jaguar Health to Present at Lytham Partners Spring 2023 Investor Conference & Participate in Animal Health Panel
PRESS RELEASE published on 05/15/2023 at 14:30, 3 years ago Jaguar Health Reports First Quarter 2023 Financial Results
PRESS RELEASE published on 05/11/2023 at 14:30, 3 years ago Canalevia-CA1, Jaguar Animal Health’s FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs, Now Available from Chewy
PRESS RELEASE published on 05/10/2023 at 14:30, 3 years ago Jaguar Health Launches AI-powered Web Portal to Support Patient Access to Mytesi, the Company's FDA-approved Prescription Drug
PRESS RELEASE published on 05/09/2023 at 14:30, 3 years ago Jaguar Completes Enrollment in Its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
Published on 05/22/2026 at 14:04, 8 hours 45 minutes ago Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Published on 05/22/2026 at 14:00, 8 hours 49 minutes ago Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Published on 05/22/2026 at 14:00, 8 hours 49 minutes ago CCL Industries Inc. Announces Renewal of Normal Course Issuer Bid and Approval of Automatic Securities Purchase Plan
Published on 05/22/2026 at 14:00, 8 hours 49 minutes ago Dateline Appoints Alvarez & Marsal to Manage Colosseum Development
Published on 05/22/2026 at 22:05, 44 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 44 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 2 hours 57 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 4 hours 16 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 4 hours 19 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 3 hours 14 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 4 hours 43 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 4 hours 43 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 9 hours 56 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 9 hours 56 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
